Clinical Trial Update: Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing pioglitazone to glimepiride in adults with type 2 diabetes inadequately controlled with metformin plus alogliptin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Glimepiride (glimepiride)
• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN